Paradigm Picks Newsletter 2022/May/31
Welcome Back,
On May 4th 2022, the Federal Reserve hiked interest rates by 50 basis points (BP’s) or 0.5%, the largest single monthly increase in approximately 22 years. Federal Reserve Chair Jerome Powell added additional 50 basis point increases will be up for discussion over the next two FOMC meetings.
In conjunction with ever-increasing tensions between the Ukraine, Russia and geo-political concerns involving the United States - uncertainty has taken ahold of overall markets. As a result, May 2022 saw an significant selloff in general markets with Crypto currency and Tech sectors being most dramatically affected.
While Macro trends in the markets were overwhelmingly bearish, we would like to point out that the S&P 500 accounts for ~80% of the broader American markets by capitalization.
All that to say - the performance of a comparatively small number of stocks (heavily favoured in the tech sector at present) can at times mislead investors to believing sentiment across all sectors is negative. Though market-wide ripple effects have occurred, we believe under the radar, Commodity, and Metals sectors show signs of recovery sooner than most.
Therein lies our value buying opportunity.
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Join the discussion on Discord!
Updates
Emerita Resources (TSX-V: EMO.V)
It’s been a tough month for the Spanish Princess. That being said, we have received fantastic updates and general sentiment regarding the stock seems to be turning for the better.
On May 10th 2022, Emerita Resources provided an update advising the much anticipated drilling permits for the “La Romanera” and “El Cura” deposits had been approved! Highlights include:
Four diamond drills initially planned to begin exploration at Romanera;
One diamond drill initially allocated for the El Cura deposit;
50 drill pads permitted on the Romanera deposit;
Initial drilling phase expected to be 15,000 Metres in size.
(Please see above link for comprehensive details regarding Romanera’s historical estimate as conducted by Asturiana de Zinc and Rio Tinto respectively.)
On May 17th 2022, Emerita Resources advised they would be expanding the initial phase of drilling on the Romanera deposit from 15,000 to 70,000 Metres! Highlights include:
70,000 Metres of drilling expected to be completed by the end of 2022;
Number of drills on site to be increased from four to six;
If required, additional drills will be acquired in order to ensure the drill program in its entirety is completed by year end;
Once completed, The company intends to publish a NI 43-101 resource estimate for the IBW project.
(Please see above link for comprehensive details regarding strike length, drill spacing, step-outs infill drilling and comments by CEO David Gower.)
Needless to say, despite recent market pressure, we are thrilled with these updates! Reaching recent lows of $1.22 CAD, EMO.V has rebounded, closing up $0.22 on Monday, May 30th from Friday, May 27th’s close to $1.74 CAD.
Today (May 31st) saw a selloff transition to a late day rally closing at $1.67 CAD with decent volume. We find this quite bullish considering the significant move Monday.
As mentioned time and time again, the IBW project continues to be de-risked while trading at a substantial discount from the stock’s previous $4.14 CAD highs. With a (future) completed 43-101 for the IBW project and an Aznalcollar decision in the wings, the company is well positioned as a future takeover target.
Manning Ventures (TSX-CSE: MANN)
Manning Ventures is a multi-sector (mineral) exploration play focusing on Iron Ore, Gold, Silver and Copper in Canada. What caught our attention most recently was the planned exploration of their 100% owned Bounty Lithium Project.
With our average position at $0.065 CAD in context with a 52-week high of $0.20 CAD; we are well positioned for future upside. Catalysts include:
Anticipation of Base/Precious metals recovery over the next 6 months;
Preliminary results from the 7,544 Hectare Bounty Lithium Project.
Insuraguest Technologies inc. (TSX-V:ISGI)
On May 10th 2022, Insuraguest Technologies provided a financial update regarding their “ISG Active” product. Highlights Include:
From December 16th 2021 to March 31st/ 2022 ISGI’s digital event based insurance produced US$260,879 in gross premiums from:
$160,826 USD in coverage for 1day ski tickets, and,
$100,053 USD in policy upgrades for additional coverage online.
The 2022-2023 will see product expansion by way of additional sales channels comprised of:
Season passes;
Pre-sold multiple-day ski tickets;
Ski tickets available for purchase on site.
On May 30th 2022, ISGI released:
Interim Financial Statements (Please see pages 3-6 and 12-16 for pertinent financial information); and,
An updated MD&A (please see pages 2-7 for pertinent financial information.)
Both documents are current as of May 31st 2022.
What captures our interest most about this stock is the company’s ability to successfully expand their coverage options.
While “insurtech” is an industry disruptor in itself, the ability for clients to purchase additional coverage outside their room or vacation home is the “holy grail” of the industry.
We believe Insuraguest Technologies is in the process of cracking this code; and as indicated by their multi-billion dollar partners and clients, people are taking notice. As a result, we have averaged our position to $0.15. CAD.
Blue Lagoon Resources (CSE: BLLG)
Following their flurry of news releases last month, Blue Lagoon Resources shows no signs of slowing down.
On May 9th 2022, the company was pleased to report continuous hits of high grade gold from their Dome Mountain Project! Highlights from hole DM-22-232 include:
“11.78 g/t Au, and 39.9 g/t Ag over 7.70m;
including 15.50 g/t Au, 68.9 g/t Au over 3.07m, and;
38.61 g/t Au and 85.3 g/t Ag over 1.10m.”
“Quinton Hennigh … commented: "Once again, drilling at the recently discovered Chance Structural Zone has generated impressive high-grade results for Blue Lagoon. The 7.7 meters intercept of 11.8 g/t Au and 39.9 g/t Ag in hole DM-22-232 occurs near a previous intercept of 7.3 meters grading 14.8 g/t Au and 38.3 g/t Ag in hole DM-21-224 announced earlier this year. Given this structure appears to be steeply dipping, it appears that the true width of this gold rich structure is perhaps 70-75% the length of the reported drill intercept, so approximately 5.0-6.0 meters, a very impressive width. I am very happy that the Company plans aggressive follow up drilling on this vein hosting structure.”
As with most stocks this month, BLLG has closed down at $0.41 CAD at the time of writing. That being said, as mentioned previously, this is another scenario where the project is continually de-risked while trading at a considerable value - especially given the recent multiple strikes of high-grade gold. We highly anticipate the continued exploration of this project.
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Paradigm Picks Newsletter 2022/Apr/30
Welcome Back,
As you are aware, as a result of international and domestic issues, the market has taken a tumble in recent weeks. It is in times like these that we go back to our fundamentals.
Short term market sentiment diverges from and masks the intrinsic value of a company. Knowing this we believe that current market conditions are presenting several value/buying opportunities.
Unless there is a material change in one of our holdings, we intend to maintain the same conviction as when we purchased the stock and look for opportunities to add to our positions. In keeping with one of our favourite quotes:
“The big money is not in the buying or the selling, but in the waiting.”
Charlie Munger.
With that in mind, here are some of the latest updates from our featured companies. Enjoy!
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Join the discussion on Discord!
Updates
Emerita Resources (TSX-V: EMO.V)
Our Spanish Princess has seen better days from a share price standpoint. That being said, the fundamentals have never been stronger! On April 7th, an update on the Romanera and El Cura deposits (IBW) was issued. Our largest takeaways from this release:
“The Company has permitted more than 50 Diamond drill sites…for Romanera and El Cura” and,
“We are ready to commence the drill program as soon as the permit is received. We have increased the number of drills on the Project to SEVEN in anticipation of the expanded drill program and one more will arrive when the program gets started.”
On April 22nd, EMO Commenced drilling with 4 rigs at the Romanera Deposit and provided significant results from the Infanta deposit. Highlights include:
"According to David Gower, P.Geo., CEO of Emerita, “The Romanera deposit is the cornerstone of the Iberia Belt West Project (IBW). Based on the historical work, it is more than 10X the size of any of the deposits known on the Project to date and has the potential to support a feasibility as a stand-alone operation in the future."
The company also received 10 assay results from the Infanta Deposit incl’ “5.5 m grading 1.2% Copper, 5.9% Zinc, 3.3% Lead, 93.9 g/t Silver and 0.41 g/t Gold.” Please see Table 1 in above link for comprehensive assay table.
As we have been saying for quite sometime, the IBW project could be a monster in its own right and rival that of Aznacollar once fully defined. From our point of view, too much focus has been put on Aznalcollar for the short term while we are developing massive projects which we already own! There is no doubt that Aznalcollar will add significant value for EMO shareholders; we are however more confident in our investment than ever as Infanta and now Romanera and El Cura are being explored. With previous highs of 4.10+ CAD, we certainly consider EMO a buy at these levels.
Please find the interview with CEO David Gower on “Small Cap Steve live” released April 5th outlining the current standings of the Aznalcollar legal situation. Here.
Cross River Ventures (CSE: CRVC)
True to our word, we have been adding in the $0.08-$0.10 CAD range as Cross River Ventures has pulled back in the short term. We see this as a value opportunity to obtain shares on the heels of CRVC’s maiden drill program and expected assays.
As a quick reminder, The company has recently completed their drill program at the “Bear Head Trend” and “Altered Zone” targets at their flagship McVicar property in Ontario, Canada. A total of 3468.5 Meters of core over 14 holes were drilled.
We continue to anticipate CRVC’s maiden assay results and look forward to the project continue to be defined going forward.
Gold Mountain Mining Corp. (TSX: GMTN)
As of April 7th, Gold Mountain Mining released additional assays from their “Elk Gold” project in the “Siwash North Zone.” Highlights include:
1.50 m grading 42.39 g/t Au including 0.30m of 207.00 g/t Au
2.31 m grading 18.90 g/t Au including 0.43m of 101.00 g/t Au
1.60 m grading 26.03 g/t Au including 1.09 m of 38.20 g/t Au
1.17 m grading 16.46 g/t Au including 0.30 m of 35.30 g/t Au
1.00 m grading 12.04 g/t Au including 0.30 m of 39.60 g/t Au
"After marching this resource passed a million ounces and making a new high-grade gold discovery in our Phase ll exploration program, we moved the drill back to the Siwash North zone for Phase lll to perform infill and step-out drilling along our high-grade mineralization," commented CEO and Director Kevin Smith. "Connecting with high-grade directly below our current mine plan gives us the opportunity to analyze bringing both the 1350 and 1400 vein into our mine plan sooner. While the mine is now into cash flow and ramping up to our proposed 19,000 oz production profile, management remains focused on continuing to scale our high-grade resource and our goal of building a multi-million-ounce gold producer."
As we have stated previously, despite market fluctuations, GMTN continues to de-risk itself. Currently sitting at $0.91 CAD, GMTN presents more value for the shareholder than it did when the share price was $2.00 CAD. We believe patience will be rewarded. The fundamentals are ever increasing; the current sentiment will change in due time.
Azincourt Energy (TSX-V: AAZ)
Another play we have been averaging down on while anticipating assay results is Azincourt Energy. As mentioned in our last newsletter, reports of elevated Radioactivity were detected during the course of their ongoing 7,000 Meter drill program at East Preston this year.
On March 31st, AAZ reported the closing of a 5.1M Private placement in addition to a 2.5-to-1 share consolidation. The company issued 63,762,500 flow-through units at a price of 0.08 CAD. Each flow-through unit is comprised of one common share and one “share purchase warrant” valid until March 31st 2024 ($0.10 CAD).
As per the news release, the company has since consolidated its shares to approximately 227,000,000 from approximately 500,000,000 as of April 15th.
Though lengthy, a video explaining the Azincourt Energy’s decision to complete a share consolidation hosted by Chris Parry of Equity.Guru (The -Gauntlet) can be found Here.
In closing, please find a more recent interview (April 20th) with CEO Alex Klenman as featured on “The Market Mindset” with Andrew O’Donnell (Digging Deeper) Here.
Blue Lagoon Resources (CSE: BLLG)
On April 4th, Blue Lagoon Resources provided a Q1 overview to shareholders. Highlights included:
The closing of the most recent $5.7m flow-through financing on March 22nd.
Crescat Capital at the direction of their strategic technical advisor Dr. Quinton Hennigh took down more than 18% of the $5.7m raise.
This financing increased the company’s treasury to approximately $9 Million.
At the time of the release, BLLG had $4 Million in-the-money warrants exercisable at $0.50 due to expire on August 12th, 2022.
CEO Rana Vig purchased 100,000 shares in the open market in the month of March.
As a result, Mr. VIG increased his personal share position in BLLG to over 3.4 million. (We are big believers in investing in companies where management collectively has a significant percentage of the company’s outstanding shares.)
The filing of a new technical report on the Company's Dome Mountain Gold Project
The new resources documented increased the contained gold oz. by 30% and silver ounces by 46% respectively.
45,000 gold ounces were upgraded to the “measured” category.
On April 11th, Crescat Capital took down nearly 50% of an additional $1.51m raise by BLLG. This instance marked Crescat Capital’s third strategic investment in Blue Lagoon Resources - a huge vote of confidence!
On April 20th, BLLG reported visible gold drill results from the “Chance Zone” at their Dome Mountain Project.
Highlights included:
16.8 g/t Au over 0.42 meters, 22.12 g/t Au over 2.14 meters and 33.08 g/t Au over 1.40 meters in hole DM-21-200
10.51 g/t Au over 1.05 meters and 14.49 g/t Au over 1.91 meters in hole DM-21-206 with visible gold
(please see above link for more comprehensive assay results)
We are very encouraged by these results and anticipate further positive news to come out of the “chance zone” as it is excavated further. Currently trading at .55 CAD we consider this stock a buy.
Railtown AI Technologies inc. (CSE: RAIL)
A relatively new stock to our holdings, Railtown AI technologies has caught our attention - and for good reason!
In speaking with management and to quote a succinctly written article by Jocelyn Aspa of “The Market Herald”:
“In a nutshell, Quality Assurance (QA) is intended to detect bugs and resolve the issues while ensuring there are preventative measures in place, so the bugs are not repeated in the future. Broadly speaking, the bug tracking software market is expected to reach just over US$600 million by 2026, significantly up from $218 million in 2018 and growing at a compound annual growth rate of 13.60% over the forecast period. Fueling that growth will be the increased need for bug-free software development in a short turnaround time and the rise in spending on software testing processes.”
“At present, it is estimated that at least 40% of development effort and time is spent on tracing and finding errors, which means tools and integrations are needed to find solutions to these problems. As such, it takes time to analyze and figure out what the root problem is and then deploy a solution and monitor its resolution. Because of this, many organizations don’t have a dedicated team or the resources to do so or find a solution in a cost-effective or seamless way.”
“In other words, simple coding errors are costing companies billions of dollars in damages and lost revenue, which is where Railtown AI and its solutions steps in. Brandolini explained that the company’s mission is essentially using AI to monitor application health and performance and detect the root causes of issues before they turn into major problems AND, in turn, become costly to resolve.”
“…Railtown’s dashboard can track efficiency gains across an organization’s development team as well as the health of the application, while also eliminating costly downtime. What this means is that critical coding errors can take hours to correct, resulting in a 42% productivity loss, which is the equivalent of over 17 hours spent on bad code and the debugging of a 40-hour workweek.”
With our lives becoming more technologically integrated than ever, we saw the immediate application of this software.
Ranging from your current word processer, web browser, financial institution, to your favourite social media platforms app creation, operating systems and more! Our key takeaway was the potential recovery of BILLIONS of dollars in damages via productivity loss etc.
In our opinion, RAIL has industry disrupting technology making it a potential take out target. Currently trading at .20 CAD, we consider Railtown AI technologies inc. a buy.
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Paradigm Picks Newsletter 2022/Mar/26
Hello everyone!
News, news and more news! Lots has been going on with our plays, some old and some more recent. Please see below update newsletter. Enjoy!
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Join the discussion on Discord!
Updates
Cross River Ventures (CSE: CRVC)
As of March 1st 2022, the company has initiated their planned 5000m drilling program at the “Bear Head Trend” and “Altered Zone” targets at their flagship McVicar property in Ontario, Canada. In speaking with management recently, CEO Alex Klenman has advised he is please with the progress made thus far and is anticipating assays from the program. We have continued to add to our position in the 0.15-0.155 CAD range as the floor appears to be firming up.
Of Note:
Bear Head Trend:
Key samples collected in 2021 include sheared and silicified mafic metavolcanic rocks which returned gold values of 19.75 g/t Au and 1.415 g/t Au.
Historic drilling at McVicar Lake in the Altered and North Flexure Zones include:
6.46 g/t Au over 10.09 m including 29.86 g/t Au over 1.86 meters.
5.5 g/t Au over 3.6 m including 12.2 g/t Au over 0.98 meters.
Gold Mountain Mining Corp. (TSX: GMTN)
Gold Mountain has been busy! Despite fluctuations in recent market conditions, GMTN’s fundamentals remain strong. As of March 22, 2022, The company received their first payment from New Gold (regarding their February 2022 Ore delivery)! The payment was in the amount of $548,862.
In addition, GMTN is anticipated to deliver 1,650 oz of gold during March 2022. Extrapolated, GMTN anticipates revenues of ~ $3 Million yearly revenue going forward!
We are very excited about this development and continue to look for opportunities to buy at these current levels - especially under the $1.50 CAD range. With the 10,000 Meter drilling program coming to a close and a future 20,000 Meter program already slated for “phase 4” we are very happy with our position and anticipate future upside as the story progresses.
Check out an overview from GMTN here.
Azincourt Energy (TSX-V: AAZ)
Azincourt Energy has been no slouch either! To kick off their flurry of coverage, On March 1st 2022, the company announced reports of elevated Radioactivity during the course of their ongoing 7,000 Meter drill program at East Preston.
The company’s attention has recently been focused on the G-zone in which extensive alteration has been discovered. In speaking with management, they are thrilled with these recent findings and plan to explore the area further. We were advised these current results are very significant and share similarities with major uranium discoveries in the Athabasca Basin such as McArthur River and Millennium!
With this news in mind we have added to our position at 0.08 CAD and anticipate a slow but steady increase in share price as the end of the drill program draws near. Certainly not least is the prospect of a significant uranium hit once the assays return from the lab! Given this news, while still an explorer, we believe Azincourt Energy is beginning to de-risk. Assays are anticipated to come back from the lab between April 2022 - June 2022.
Blue Lagoon Resources (CSE: BLLG)
We’ve also seen a steady stream of news from Blue Lagoon Resources. On March 17th 2022, The company reported results from their recent drill program with significant assays coming out of the newly discovered “Chance Structural Zone.” Highlights included:
“DM-21-200: 53.60 g/t Au and 55.46 g/t Ag over 0.55 meters within 33.08 g/t Au and 72.30 g/t Ag over 1.40 meters within 22.12 g/t Au and 47.95 g/t Ag over 2.14 meters.
DM-21-188: 49.40 g/t Au and 56.90 g/t Ag over 0.32 meters followed 7.55 meters further down hole by 11.79 g/t Au and 61.50 g/t Ag over 0.47 meters.”
BLLG’s recent efforts have continued to garner the attention of word renown geologist Quinton Hennigh and the heavy weights at Crescat Capital. As a result, in BLLG’s March 22, 2022 release, Crescat Capital took down an 18% portion of their recent $5,746,893.84 private placement!
We find this accumulation by Crescat Capital to be an incredible vote of confidence. In addition, Crescat Capital provided an update for Blue Lagoon Resources on their Youtube Channel As a result, we have taken the opportunity to add to our position during the recent pullback into the Mid 0.50’s. The stock has since settled at 0.60 CAD.
In addition, “The Deep Dive” conducted a comprehensive interview with CEO Rana Vig. Leah on the Daily Dive discusses recent movement in the spot price of gold, and Blue Lagoon’s “path to production” with a comprehensive summary. As always, we are big fans of CEO’s owning significant sums of their stock; we consider this to be the ultimate gesture of confidence in one’s company. Rana of course has been continuing to add to his holdings during March 2022.
NHP Luminera Health inc. (TSX-V: NHP)
Luminera Health inc. has been busy working on their distribution channels. As of February 15th 2022, the company signed a binding agreement to launch their Awaye(TM) pain relief product in the United States. Shortly thereafter, NHP appointed Jacqueline Khayat to the board of the directors to assist with expansion into the United States markets.
To follow up, On March 22, 2022, the company reported 25% growth in Q1 2022 over Q1 2021 with Bazzics sleep aids and the Awaye(tm) pain cream leading the way!
Finally, on March 24, 2022, NHP signed a distribution agreement to launch their Awaye(tm) product in Vietnam! Needless to say, we are very pleased with the progress made thus far at the hands of CEO Carlos Ponce and team. We continue to look for opportunities to purchase shares at 0.015 CAD however those opportunities are becoming fewer and further between! 0.02 CAD continues to make attempts and being the new floor especially with the flurry of recent news NHP has released.
RooGold inc. (CSE: ROO)
Another company we’ve had our eye on is Australia based gold explorer: RooGold inc. At the current share price of 0.145 CAD, we believe a fantastic value opportunity has presented itself.
On February 17th 2022, The company laid out their explorations plans for Q1 and Q2 of 2022. Their work program consists of:
“Acquisition of high resolution satellite and DEM data to provide a base for structural mapping and reconnaissance planning.
Establishment of a land-owner database and negotiation of land-owner access agreements for priority targets.
Reconnaissance mapping of six priority concessions, which will be followed by prospect mapping and target generation for the initial top three prospective properties.”
On March 10th 2022, RooGold commenced exploration on their New South Wales properties. A total of 47 rock chip samples were obtained. Field work is underway at the Lorne Concession outcrops. Finally, the Peel South Concession is under application. Following the completion of this application, the company’s Australian land holdings will be nicely consolidated.
A comprehensive article by “Ahead Of The Herd” is a worthwhile read. A more recent article from them can be found here.
As noted in the first article, this company has once again caught the attention of one of our favourite Geologists, Dr. Quinton Hennigh!
Though very much in its infancy, we believe RooGold is a value buy with risk offset by the size of their collective 1,091 km2 land packages in both the New England and Lachlan Orogenic areas.
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Paradigm Picks Newsletter 2022/Feb/24 (BLLG)
Welcome Back!
We would like to bring your attention to one of our new holdings, Blue Lagoon Resources. Please see below for brief overview and additional updates.
We have been reaching out to the CEO’s of our investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Join the conversation on our New Discord channel!
Feature
Blue Lagoon Resources (CSE: BLLG)
In speaking with CEO Rana Vig, we were very impressed and compelled by Blue Lagoon Resources’ story and potential upside. We took a sizeable position at $0.35 CAD approximately one month ago. We are currently sitting at a gain of ~50%!
Please see below for company overview:
Approximately 25% insider/friends and family ownership
17% European ownership (traditionally long term holders)
Shares issued and outstanding 88,669,182
Options 2,837,500
Warrants 8,999,074
Fully diluted 100,505,756
Raises over the past two years were:
2020 - $2.2 Million raise at $1.00.
2021 - Oversubscribed $8.13 Million raise at $0.55 with a two year half-warrant at $0.75.
Current share price ($.53 CAD) is below the average of both private placements.
Waiting on 28 holes to report (huge backlog)
Excellent entry point with significant news pending.
Cash on hand: ~$4 Million in treasury.
Currently $4.5 Million of in-the-money warrants which can be exercised at $0.50.
These warrants expire in the summer of 2022. The company has the right to force conversion should it deem necessary.
No outstanding debt
Dome Mountain (Flagship Project) 21,541 hectares
Prior to current CEO Rana Vig taking over the company, $28 Million spent in the last 12 years; in addition to $40 Million previously spent by Timmins and Noranda on the Dome Mountain Project for:
Mine permitting
Infrastructure
Construction
Underground development
Exploration drilling
VTEM imaging
Management Recently completed $2 Million in required amendments in order to renew their Dome Mountain mining permit.
The amendments will be submitted shortly to the Ministry of Mines which should have (at most) a 4 month turnaround time.
Rana Vig has spoken with the Ministry on several occasions; they are very interested in seeing the mine come back online should all the amendment criteria be met.
Permit to be renewed for 75,000 tons/year (gold).
Works out to approx. 25,000 oz gold/year.
Consistent progress and communication from this company has also caught our attention. Blue Lagoon Resources hit the ground running in 2022 with the following news releases:
On January 26th 2022, BLLG commenced a 20,000 Meter drill program on their Dome Mountain project
On February 3rd 2022, BLLG added a second drill rig to the site.
In addition, BLLG filed an updated resource report resulting in:
A 145% increase of gold in the “indicated category” on the project (with limited drilling thus far).
On February 7th 2022, BLLG released gold intercepts including 14.8 g/t AU and 38 g/t AU recently discovered in the “Chance Zone” on the property.
On February 14th 2022, BLLG advised their fourth shipment of Gold and Silver Concentrate (totaling 103 Tons from the Dome Mountain project) was ready to be sent to “Ocean Partners UK Ltd.”
This shipment will provide BLLG with over $500,000 further adding to their treasury.
In 2021, 223 tons (in three installments) of concentrate were shipped providing BLLG with $1,000,000 CAD.
It is important to note:
all mineralized material was mined by BLLG’s previous ownership from the “Boulder Vein” - at the time they were unable to have the material processed.
Two First Nations bands have land on the property. Half of all BLLG’s staff are First Nations and have fantastic relations with the bands as per the CEO. No perceived mining issues currently or going forward.
The second Band has claim to a small northern portion of the property.
however ,this portion has not been worked on and is not in the queue for drilling at this time.
Dome Mountain is approximately a 45 minute drive to site from town.
Managements intention is to use Dome Mountain to generate cashflow for future drilling their other project.
With this strategy, the company hopes to limit future dilution going forward. The other project being:
Pellaire Gold project. 7,100 hectares
Which has 10 high grade known veins.
We are very excited about this particular business model in using one project to fund several others. In addition We are happy to see deposits of not only gold, but Copper and Silver as well in their portfolio.
World Quinton Hennigh considered Blue lagoon to be a “hidden gem.”
Hennigh has since advised US based fund, Crescat Captial to invest in BLLG.
Based on this recommendation, Hennigh has since been brought on to consult for the company.
Please see coverage from Quinton Hennigh On Blue Lagoon Resources for further information.
Based on the above catalysts in conjunction with the current share price of $0.54 CAD we believe BLLG will create a 2x in value from here over the next 12 months.
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
Paradigm Picks Newsletter 2022/Jan/20
Happy New Year!
We are excited to get back to the markets and are looking forward to what 2022 has in store. There are a number of companies we are looking at and will keep you updated should they make the #paradigmpicks cut!
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Join the conversation on our New Discord channel!
Updates
A new acquisition of ours in the nutraceutical space is Quebec, Canada based Lumiera Health inc (TSXV: NHP)
The company owns three product lines under:
Holizien Laboratories: Herbal and tonics supplement division with approximately 20 years experience and 40 offerings in their product line.
Bazzzics a top seller of Holizen Labratories specializing in natural sleep aids. These products have most recently been listed for sale on Well.ca!
Away Pain Relief Cream A first of its kind, non-addictive topical cream with two active ingredients in Capsaicin and B-Caryophyllene. This product has been clinically tested.
All products approved for use by health canada.
Currently, the company is distributing its products throughout 130 locations in Quebec by way of:
Rachelle Béry,
Avril,
Tau,
La Moisson,
Concerning the rest of Canada, Lumiera is engaged with a distributor providing access to 2500 retail accounts and 2500 professional accounts.
In speaking with newly appointed CEO Carlos Ponce, multiple new contracts and discussions regarding expansion of existing distributors are underway. In addition, discussions are underway to enter the United States and European retail markets.
As some of you may know, Lumiera Health inc. (formerly Mondias Natural Products inc.) had run into organizational/managerial issues prior to Mr. Ponce’s appointment as New CEO approximately halfway through 2021. Since taking the reigns, Mr. Ponce has been involved with restructuring the company, from “trimming the fat” in so far as inefficient positions, staff, bloated salaries and the cancellation and renegotiation of unprofitable distribution contracts.
As a result of Mr. Ponce’s efforts, Lumiera has increased sales from November 2020 to November 2021 by 59% (press release). In addition, the company plans on being profitable by the end of fiscal 2022.
Given the deep discount of the current share price (0.015 CAD) in conjunction with Mr. Ponce’s concerted restructuring efforts, we believe an opportunity has presented itself. During restructuring, a company’s efforts are often forgotten or overlooked. We have taken a position with purchases at 0.015-and 0.02 anticipating a 2.5-3x by the end of 2022.
We believe that the current market cap of the stock is currently represented by previous management’s failings. Once word gets out regarding the strides the company is making under Mr. Ponce’s purview we believe a gradual re-rating will take place.
Please see Lumiera - MDA Q3-2021.V2 (sedar.com) for a detailed breakdown of private placements, salaries and operating costs in chronological fashion.
Taken from the MD&A (summarized):
On July 12th, 2021, the company closed a private placement which consisted of the issuance of 52,000,000 Units at a price of $0.025 per Unit for gross proceeds of $1.3 million. Each Unit consist of one common share in the capital of the Company and one common share purchase warrant, with each Warrant entitling the holder to acquire one additional Common Share, at an exercise price of $0.06 per share, for a period of four years from the date of issuance.
On October 8th, 2021, the company closed a Private Placement which consisted of the issuance of the issuance of 18,333,335 Units at a price of $0.030 per Unit for gross proceeds of $550,000. Each Unit consist of one common share in the capital of the Company and one common share purchase warrant, with each Warrant entitling the holder to acquire one additional Common Share, at an exercise price of $0.06 per share
In asking about treasury health and future private placements, Mr. Ponce stated in, part, that:
the company will look for additional funding only if a strategic acquisition which assists in building on current momentum to reach profitability presents itself.
Cross River Ventures CRVC : Touching .19 CAD at close on January 19th 2022, Cross River Ventures has surged back to life! We hope you all took heed of our conviction in this stock and continued to buy in the .12-.15 range. We were fortunate enough to average our position down to .165.
This momentum continues to be aided the resurgence of precious metals (especially gold) in recent days.
In addition, anticipation of CRVC’s planned 5000m Drill program at their McVicar Gold Project (Q1 2022) is certainly renewing interest as reflected in the share price in recent weeks.
Finally, CRVC’s issuance of .17 options to management etc prior to breaking ground on this year’s drill program is very telling. We believe this is a huge vote of confidence for what is to come.
Should the spot price of gold reach $1900 Oz USD, in conjunction with a successful drill program; we would not be surprised to see the share price return to the .50+ Range
Gold Mountain Mining Corp. GMTN : Since up-listing to the TSX, Gold Mountain Mining Corp has been under selling pressure falling as low at $1.18 CAD in January 2022 from highs of $2.22 CAD last year.
Despite this, we hope you took note of our tweets and added to your position at these value prices. It appears that up-listing to the TSX may have garnered unwanted attention of short sellers in the near term.
While an annoyance, this short selling has presented a fantastic opportunity. We believe the share price has been artificially suppressed in the short term.
The share price is currently trading lower than before the Mining permit was approved! In essence, the stock has continued to be de-risked while trading at a significant value. There has been no material change regarding this stock, and as such, we hold fast to our thesis:
This is a company with management that has a track record of completing their goals in a timely fashion. In addition, management is currently not drawing a salary from the company, opting instead to invest and reinvest all funds generated back into the company for maximum efficiency. As previously mentioned, The share price should additionally see a lift from the increase in gold prices as they continue to rise.
Azincourt Energy AAZ : It’s drilling season! Azincourt Energy has completed the majority of the preparation/infrastructure for their 6000m 30-35 hole drill program at East Preston this winter. In speaking with CEO Alex Klenman, Preparation for the drill program has been,
“coming along very well!”
We can also anticipate an update speaking to drill rigs on site shortly. With each passing drill program, we believe Azincourt energy is continuing to narrow in on a uranium discovery. We are happy to add in the .065-0.07 range as any discovery would most certainly result in a buy out. Stay tuned!
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Paradigm Picks Newsletter 2021/Dec/02
Welcome Back!
It’s the most wonderful time of the year! Tax loss season! We hope you all set funds aside for the pullback that was November! We have continued to buy dips as they have presented themselves in our various holdings. We are looking forward to more deals this month and excited for January 2022!
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Join the conversation on our New Discord channel!
Updates
Emerita Resources EMO : What an eventful November for the Spanish Princess! Between:
Anticipation of the recent PP coming free trading last month,
a news article out of spain dissemingating false information on the Aznalcollar tender,
False reports of work being conducted on the Aznalcollar property and,
EMO.V surging as high as $4.14,
we saw some significant downside pressure. Fortunately (and unsurprizingly) the news article suggesting Emerita had no right to the Aznalcollar tender was debunked.
Regarding the private placement coming free trading last month, we were greeted with some fantastic news regarding Eric Sprott. As stated In the November 15th 2021 News release,
“ Mr. Eric Sprott, ….., exercised a total of 6,818,181 Warrants at an exercise price of $0.30 per common share (“Share”).
Following the completion of the exercise of his Warrants, Mr. Sprott beneficially owns and controls 20,454,544 Shares, representing approximately 10.7% of the issued and outstanding Shares on a non-diluted basis. Prior to the Warrants exercise, Mr. Sprott beneficially owned and controlled 13,636,363 Shares and 6,818,181 Warrants, representing approximately 7.4% of the issued and outstanding Shares of the Company on a non-diluted basis, and 10.7% on a partially diluted basis.”
We were incredibly encouraged by Sprotts decision to “double down” on EMO.V being one of the most significant votes of confidence for the stock in recent memory.
Speaking of “votes of confidence,” once again we give a tip of the cap (pun intended) to “Doc Jones the Resource Investor” and management for the fruitful Due dilligence that came out of the recent site visit. Please see below regarding the insightful interviews Doc Jones provided:
Interview with EMO President Joaquin Merino
Interview with David Gower Re: Site tour
One of our biggest takeaways regarding the site tour information was the fact that Emerita plans on expanding the number of drills on IBW alone to EIGHT! In addition, feedback regarding the Aznalcollar property being put back in to production was very well received by the surrounding communities.
We thought we would add one additional note regarding future speculation. There is much excitement and interest regarding the Neuvo Tintillio property. While we agree with the addage a “bird in the hand…, we are further intruiged at the potential (positive) divergence between historical samples and future drill programs regarding Aznalcollar. Recent assays from IBW returned upwards of 60% higher grade compared to historical. Given the proximity of the two projects in conjunction with modern technology/mining methods, it is not out of the question to suggest that future mining at Aznalcollar could also yield higher grades than previously documented.
With this information, we have moved our (conservative) buyout price range to ~$25.00 CAD!
Bright Minds Biosciences DRUG : Bright minds Biosciences fell from recent highs since their listing on the NASDAQ. Naturally We have been adding and averaging down our position. Our confidence is further bolstered by the fact that CEO Ian Mcdonald had purchased over $100k CAD worth of shares in November 2021 as per SEDI! We believe any buys under $7.50 are of fantastic value with a longterm perspective.
As of November 30st 2021, Bright Minds Biosciences issued a news release regarding their Novel 5-HT2A Psychedelic Program
“Our 5-HT2A psychedelic drug discovery program is showing clear signs of success,” stated Dr. Alan Kozikowski, Ph.D., Chief Scientific Officer and Co-founder of Bright Minds. “To date, we have synthesized hundreds of de novo, novel compounds in our discovery program and are currently optimizing a select handful of the most encouraging molecules to take into late preclinical development. We are currently on track to announce our lead molecule in this program in the first quarter of 2022.”
As mentioned in previous issues, we believe Bright Mind’s biosciences along with the psychedelic’s market in general is still in its infancy. We have no issues adding sub $7.50, especially ~5.10!! We are certainly looking forward to gains from this stock in 2022.
Gold Mountain Mining Corp. GMTN : Gold Mountain has been busy! Since our last issue, they have been issued their permit from the ministry of mines, uplisted to the TSX and released assays including one of the widest recorded high grade intercepts at the Elk Property!
Drilling Highlights Include:
2.4m grading 20.2 g/t Au including 0.4m of 127.0 g/t Au
1.3m grading 6.87 g/t Au including 0.3m of 28.6 g/t Au
1.3m grading 4.48 g/t Au including 0.3m of 19.4 g/t Au
1.3m grading 4.25 g/t Au including 0.3m of 18.4 g/t Au
Given the recent retracement to $1.42 CAD, we see these levels as significant value as Gold Mountain agressively develops their project. Another company we belive will do well 2022!
KULR Technology Group inc. KULR : We hope you picked up a few more of these of these shares! KULR’s media team has been out in full force garnering coverage from multiple youtuber’s and news outlets. The coverage, in part has been due to KULR’s recent order from Lockheed Martin! See below:
KULR Technology Stock Is On A Run; Adds To 140% YTD Gains After - SOUTHEAST - NEWS CHANNEL NEBRASKA
As a result, the KULR share price has exploded to the upside from our original sub $2.00 USD buy recommendation to $3.47 USD at the time of writing. As the world continues to rely on clean and effecient energy/ storage management, you can bet KULR will continue to be at the forefront in 2022.
Insuraguest Technologies inc. ISGI: Tax loss season has not been friendly to Insuraguest Technologies - which is exactly why we are buying here! We believe that the market reaction to ISGI’s initial revenue was unfair and significantly oversold; this is an industry disrupting technology in the early stages of worldwide implementation. We are more interested in year over year revenue increases which we believe to be substantial. As mentioned in previous issues, when multi-billion dollar insurance agencies knock on your door, you know the returns will be significant down the road!
Speaking of which, as of December 2nd 2021, ISGI has announced an additional partnership with Suitelife! The share price at the time of writing has spiked has high as .24 CAD compared to brief lows of .18!
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Paradigm Picks Newsletter 2021/Oct/26
Hello there,
What a crazy few weeks it’s been!
We thought it best to provide another update, especially with the significant movements in Emerita Resources.
We have been reaching out to the CEO’s of our investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Updates
Emerita Resources EMO : The worm has turned, and for good it seems! The last few drill results from IBW have been absolutely INCREDIBLE surpassing historical documentation as much at 60%! (News Release)
If you follow our twitter handle, we noted the market seemed to be sleeping on IBW and its recent assays in anticipation of Aznalcollar. It now appears that IBW could potentially be the larger of the two assets! Time will tell, but we like our chances. We could soon be sitting on two titan-sized, world class resources!
Reaching recent highs of $3.45 CAD before a healthy pullback, Emerita Resources is looking strong, poised for additional upward momentum in the near term. The continued trend is fueled in part on recent news of Clarus securities updating their price target (not including Aznalcollar) approximately a full dollar to $4.50 USD or approx. 5.50 CAD! We consider this valuation to be very conservative and believe it will be revised as additional assays from IBW are released.
Keep in mind there will always be consolidation after a big move which is healthy for the stock. Simply look at the last year of trading and you will see why aren’t concerned regarding any future price fluctuations.
Please find the link below for a worthwhile video on “Small Cap Steve” where “Dr. Jim Jones” is interviewed and clearly lays out the data and valuations going forward:
$EMO Emerita Resources w/ Doc Jones. Gold & Uranium. - YouTube
Please find below another interview with CEO David Gower by “The Deep Dive:”
Emerita Resources - Aznalcollar & IBW Update w/ David Gower. [$EMO.v] - YouTube
We firmly believe that with Aznalcollar and time to develop the expansive resources, Emerita resources will be an $18.00+ USD/ $22.00+ CAD stock!
Insuraguest Technologies inc. ISGI: Despite recent pullbacks, long term we are very bullish on Insuraguest Technologies. Currently trading at 0.26 CAD it appears as though as bottom is forming.
Our impression on ISGI is that the market as a whole doesn’t really know what “insurtech” is. As a result, many do not know how to value this stock or understand the industry disrupting potential it has. We believe that once financials have been established, ISGI could comfortably rise into the $1.00-$1.50 range. It is in this lull where a fantastic opportunity to add presents itself.
It’s important to remember ISGI’s previously stated profit margins of 60%-80% (Hub int’l and GUESTY respectively). In addition, ISGI has garnered a business relationship with Airbnb through GUESTY.
ISGI has been forming these additional partnerships without much attention (News releases). They are continually expanding their insurance network in order to obtain a significant market share within the insurance/insurtech space.
In addition to these heavyweight companies, ISGI has been aggressively sought after by a number of agencies such as:
Centred,
USI Insurance Services
Hostaway and
Ownerez
among multiple others.
At 0.25-.30/share, we still consider Insuraguest a strong buy with significant future upside. We are eagerly awaiting their upcoming financials and anticipating them increasing year over year.
KULR Technology Group inc. KULR : Hope you all saw our previous newsletter and were able to purchase below $2.00 USD! After a brief slip below $2.00 support, KULR has been charging upward reaching highs at the time of writing of $3.11 USD! For additional insight into this company please see below video of youtuber “Deadnsyde:”
This $2 Stock Might 2X (Why I Just Bought) NASA + BITCOIN + 400% YoY Growth - YouTube
We are very happy with this stock’s performance and anticipate growth past its most recent price target of $3.50.
Azincourt Energy AAZ : Azincourt Energy has recently received DTC eligibility. In addition to Uranium’s rising spot price, we are seeing significantly increased volume in the 0.08-0.095 CAD range.
The final tranche of AAZ’s non-brokered private placement was closed on October 12th 2021. As a result they are well funded for additional exploration their East Preston project in the Athabasca basin. The drill program is anticipated to be ~7000m in size. We continue to like AAZ’s chances of a discovery given the historical data in the Athabasca basin and cutting edge survey techniques that are being implemented.
As many of you are aware, Uranium can be a fickle investment resulting in feast/famine in the sector. We believe Uranium is just beginning to enter a bull cycle in which many of the potential catalysts for AAZ and other Uranium plays could result in significant returns.
Please see below link for youtube video with Alex Klenman and Trevor Perkins as featured at the “Red Could Oktoberfest Fall Mining Showcase 2021” for additional updates:
Azincourt Energy - Red Cloud Oktoberfest 2021 - YouTube
As always, we remain bullish long-term on this stock anticipating a discovery which will ultimately result in a buyout by one of the several major’s in the area. Given Uranium’s recent momentum, should AAZ make a discovery during this drill program, all bets are off as far as buyout valuations are concerned!
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Paradigm Picks Newsletter 2021/Oct/11
Hello everyone!
Wishing all of our Canadian Subscribers a happy Thanksgiving weekend! A lot has happened since our last edition!
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions, however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Updates
Emerita Resources EMO : Congrats to all who have held through the storm! After several weeks of downward pressure, sold as low as $1.26, Emerita has returned with a vengeance hitting a daily high of $2.15 and closed for the second time above $2.00 at $2.07 with over 2.3m shares traded on the Canadian side alone! The main reason for this parabolic move, was the recent news release in which:
The Administrative Court of Andalucia has advised that it will be making a ruling in the administrative case initiated by Emerita in 2015 regarding Aznalcollar. As a result, Aznalcollar may be awarded much sooner to Emerita Resources than previously anticipated, potentially bypassing criminal trial entirely. Regardless, all three levels of spanish courts have agreed that crimes have been committed in the issuance of the Aznalcollar property. Should the Administrative case be deemed unsatisfactory to the courts, the criminal trial will proceed.
Despite an initial selloff on exceptional drill results regarding Emerita’s IBW property, the market finally received the “nod” it was looking for; the Acquisition of Aznalcollar by Emerita Resources is all but guaranteed. Clarus securities updated their acquisition target to $6.25/share! At the time of writing, we are sitting on a 2024% gain!
We agree with “Doc Jones the Resource Investor” that once both properties are completely drilled out, Emerita resources could fetch a buyout price of $18.00-20.00+ CAD per share in ~2 years. Please find Doc Jones’ interview with CEO David Gower regarding recent updates and the vision for the company going forward.
Bright Minds Biosciences DRUG : Bright minds Biosciences Recently jumped at open to as high as $10.77 share before slowly settling back to $9.00 CAD. Our speculation is that news of the a NASDAQ listing is fast approaching and have positioned ourselves accordingly. Clinical trials are still planned for the end of 2021.
Cross River Ventures CRVC : The Precious/metals sector as a whole has been hit hard as of late. Cross River ventures is no exception to this downward pressure. Regardless, we believe the long term thesis is intact and have added to our position in the .12-.13 range.
These purchases were initiated by recent Grab sample results which we believe are a great indicator for what is to come. It is important to note that as of the last few trading days, CEO Alex Klenman has purchased the stock on 5 separate occasions as per SEDI. This further instills confidence in our purchase decision.
Gold Mountain Mining Corp. GMTN : Gold Mountain is one of several new additions to our investment portfolio. We have amassed a sizeable position at a $1.55 Average and have added recently into the $1.80 range as we continue to dig into this company’s story.
In speaking with management, No insiders draw a salary from any funds generated by the company. All management and insiders possess other revenue streams and are committed to reinvesting all acquired funds from the company back into exploration, mining and production. From this fact alone, we were sold!
As per notes below, the company has applied for a mining permit. Upon issuance, we suspect the share price to increase to the $2.50 range and develop from there.
Please see below for a brief summary of additional details pertaining to Gold Mountain Mining Corp.:
Approximately 810,000 Oz High Grade Resource has been discovered thus far in Siwash North of the Elk Gold Project in Merrit, B.C, Canada. This property Property had an approximate 375,000 Oz defined resource when when purchased By Gold Mountain in May of 2019. The Elk Gold Project is approximately 16,700 Hectares in size. Gold mountain Resources is currently Drilling out 4 zones on the property with the goal of increasing their resource to 1,000,000 Oz by end of November 2021.
As per July 12th 2021 news release, The company is currently awaiting approval for their mine permit from the Ministry of Mines. Once this permit is approved, it will mark the first Gold Mining permit issued in the Province of British Columbia in nearly a decade.
Regarding financials, the Company has over $10 million in their treasury and are well-heeled for all upcoming expenditures.
Gold Mountain Resource Corp has a very appealing share structure with only 70 million shares issued and outstanding. Circling back to management and insiders, they are not drawing from the company treasury; this ensures the company will not have to issue a financing anytime in the foreseeable future.
KULR Technology G roup inc. KULR : Another addition to our portfolio, KULR Technology Group is a U.S based company specializing in the battery space. KULR’s goal is to assist in the greater efficiency and safety of Battery powered electronics and transportation.
KULR’s battery techonology has garnered business from NASA and the United States Federal Government. In addition, KULR is currently in discussions with several larger companies currently under NDA’s.
We believe KULR is currently positioning itself to be at the core of the growing demand for:
Clean energy,
Portable Devices (phones, laptops, radios etc),
Battery Safety,
Battery Longevity, and;
Lower Emissions.
As of October 6th 2021, KULR issued a press release advising their “Safe battery transportation footprint [is in the process of being] expanded due to Heritage Battery Recycling’s Merger with Retrieve Technologies.”
As a result, we believe KULR is quite undervalued at $1.96 USD. Though the stock as seen a surge and subsequent pressure in recent weeks, we believe purchases in the $1.85-$1.95 are an excellent value buys for a longer term hold.
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
Paradigm Picks Newsletter 2021/Aug/27
Hello everyone,
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Updates
Emerita Resources EMO : After hitting all-time highs of $2.16, Emerita resources has pulled back consolidating in the $1.78-1.84 range. Recent news releases confirming and surpassing historical results are very encouraging and continue to firm up the new floor. At the time of writing, we are up 1716% and do not plan on selling any time soon. With 4 drills soon to be operation simultaneously at IBW, a steady flow of assays both new and to confirm historical resources, EMO.V possesses incredible upside. In addition, The acquisition of Aznalcollar is looming. We certainly would not want to be caught flat-footed when acquisition news hits! EMO.V is an 18 month + hold for us. We are waiting for a conservative valuation of $10-15/Share CAD and will reassess as the story progresses.
Bright Minds Biosciences DRUG : Bright minds Biosciences has been making moves as of late, topping out recently in the $7.05 range. In speaking with management, we are assured that many facets of the company are progressing well behind the scenes. Bright Minds Biosciences recent news release speaks to their Proprietary “5-HT2C compound” which has shown significant reduction in seizures. These results are very encouraging. We have been appraised that additional patents are underway and clinical trials are planned for the end of 2021.
Cross River Ventures CRVC : As per the recent news release, Cross River Ventures has recently completed Phase one field work at the Manitou, Shabou, Dent-Jackson projects with the following highlights:
1): 126 grams-per-tonne ("g/t") gold ("Au"), 8.28 g/t Au, and 2.73 g/t Au
2): 17.8 g/t Au, 13.2 g/t Au, and 8.43 g/t Au
3): 26.7 g/t Au, 24.6 g/t Au, and 15.5 g/t Au
CEO Alex Klenman, advised these initial samples were very encouraging however only the beginning of this expansive project. We have continued to add in the .16-.175 range keeping in mind this stock was previously at highs of ~.50/share. As we have mentioned before, the weakness in the gold and precious metals sector seems to be the main contributor to the current share price. In our opinion, now is the time to add as Gold has recently pushed through $1800 once again.
Azincourt Energy AAZ : As per recent news release, Azincourt Energy Corp has eleveated Trevor Perkins’ position to Vice President of Exploration. Mr Perkins resume includes:
Exploration manager at UEX Corporation; he managed the team which made the Aurora Uranium deposit discovery in 2017,
Senior Geoscientist with Rio Tinto,
Vice president of exploration at Cameco in various districts.
Expanding Mr Perkins’ role in the company speaks to confidence in his leadership and ability to produce. at 0.05/share, we consider Azincourt a buy for long a term investment.
Insuraguest Technologies inc. ISGI : Insuraguest has recently appointed Reed Wright as President of the company. This strategic acquisition in Mr Wright speaks to the deals that Insuraguest ongoing behind the scenes. In our opinion, the most appealing aspects of the company are:
High profit margins,
Ease of access, and
Scalability.
Speaking of which, Insuraguest has recently signed a vender agreement with OwnerRez. At 0.35/share, we consider Insuraguest a strong buy with significant future upside.
Nexus Gold Corp. NXS : Nexus Gold Corp recently issued assays from their Dakouli 2 Gold Project, located in Burkina Faso, West Africa including:
12 meters of 1.18 grams-per-tonne (g/t) gold (Au), within a broader intercept of 30 meters of .52 g/t Au, which also includes
.86 g/t Au over 17 meters, 2.19 g/t Au over 6 meters,
6.51 g/t Au over 2 meters, and,
12.7 g/t Au over 1 meter.
18 meters of .37 g/t Au, including 2.22 g/t Au over 2 meters.
Additional programs are underway to continue to build out and define the resource.
In closing, we have several additional companies we look to be adding to our portfolio and showcase soon. Stay tuned for additional info!
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Levitee Labs inc. LVT.CSE
Sector: Healthcare, Psychedelics, Alternative Medicine, Mental Health and Nutraceuticals
Focus: Integrative Wellness, Synergistic Acquisitions and Vertical Expansion
Levitee Labs is an integrative wellness company that is transforming the digital landscape of mental health, addiction treatment, and pain management. The Company operates as an efficient capital allocator through a growing portfolio of revenue-generating wellness assets that have highly synergistic qualities for extensive psychedelic adoption and integration.
Sector: Healthcare, Psychedelics, Alternative Medicine, Mental Health and Nutraceuticals
Focus: Integrative Wellness, Synergistic Acquisitions and Vertical Expansion
Company Overview:
Levitee Labs is an integrative wellness company that is transforming the digital landscape of mental health, addiction treatment, and pain management. The Company operates as an efficient capital allocator through a growing portfolio of revenue-generating wellness assets that have highly synergistic qualities for extensive psychedelic adoption and integration.
Comparable Companies:
Field Trip Health (TSX: FTRP) (Market Capitalization: ~$412.1M) – the company runs ketamine infusion clinics across Canada and the US, in addition to building clinics to administer psychedelic therapies
Numinus Wellness (TSXV: NUMI) (Market Capitalization: ~$198.9M) – the company has an acquisition model for acquiring clinics and administering psychedelic therapies
Cybin (NEO: CYBN) (Market Capitalization: ~$525.1M) – a biotechnology company that focuses on the development of psychedelic therapeutics to treat various psychiatric and neurological conditions
Levitee Labs (CSE: LVT) (Market Capitalization: $39.7M)
The Company has huge potential for re-rating and upside with
the psychedelics market being valued at over $100B as of 2021
Levitee Labs possesses an approximate Enterprise Value (EV) of $26M
The average EV in the health & wellness psychedelics space reaches north of $300M (~11.5x sales multiple)
Financials:
Levitee Labs raised $10.5 million in its last financing round, which was held in escrow until the Company’s listing on the CSE on July 21st, 2021
The Company is committed to building a portfolio of cash-flow generating assets as highlighted by Levitee’s expected acquisition pipeline of over $500M
Levitee Labs projects a 2021E revenue of $15.4M and EBITDA of $1.4M
The Company is expected to be the first EBITDA-positive psychedelics company
The Company has constructed a diversified portfolio with an expected 77% of incoming revenue being derived from acquisition targets and 23% from internally developed assets such as Monke Nutraceuticals and Sporeo Supply
Divisions:
Newly completed and certified production facility in Port Coquitlam, B.C.
Produces the first commercial-grade offering of sterilized grain and
substrates for small to large-scale mushroom cultivation
Anticipated revenue of $1.2M per month with $800,000 in positive cashflow
Based on a monthly purchase agreement with MyGreenPlanet
Mushroom-focused supplements containing clinically assessed levels of bioavailability for polysaccharides and beta-glucans
Organic mushroom fruitbodies extracted 8-10x
Utilizes a variety of certified organic, non-GMO, gluten-free, adaptogens and nootropics
The product has 41% profit margins
Levitee Clinics:
Levitee has recently acquired six mental health, pain and addictions focused clinics with over 35,000 patients
These clinics specialize in pain and addiction management
This acquisition will make Levitee the largest non-government addiction clinic services provider in Alberta
70% of patient visits conducted through the clinics’ proprietary telemedicine technology, which is the first (provincially) to prescribe narcotics over telehealth
Levitee Pharmacies:
Levitee has acquired three pharmacies specializing in management of pain and addictions
The combined revenue of the healthcare-focused acquisitions is approximately $7.5M over the last twelve months with over $1M in positive cashflow
Business Model:
Levitee has assembled a comprehensive team with a wide range of expertise in complementary fields in order to:
Develop key partnerships,
Raise capital,
Identify key acquisition targets,
Pursue clinical initiatives,
Expand profitability of newly acquired assets resulting in:
Multiple revenue streams with which to continue this “Roll Up” business model
Management & Board of Directors:
Pouya Farmand – Chief Executive Officer & Co-Founder
Mr. Farmand is an experienced financier and entrepreneur with over 10 years of transaction experience in capital markets and M&A
He has been involved in a leading advisory role for over 35 transactions ranging from $1M to $50M
Kelly Abbott – Chief Operations Officer & Co-Founder
Mr. Abbott has over 10 years of experience in entrepreneurship and software development
He has previous experience as a successful founder, investor, and CEO, having owned and operated several private and public companies
Ken Osborne, CFA – Head of M&A, Co-Founder
Mr. Osborne is a capital markets professional with diverse experience and is currently a General Partner at Darkhorse Partners having previously worked as a Corporate Development Manager within the Mergers & Acquisitions group at Telus (TSX: T) (NYSE: TU)
He has covered over 20 capital raises with an aggregate transaction volume of approximately $500M in M&A activity
Yarrow Willard – Director
Yarrow is a second-generation Clinical Herbalist, Master Herbalist, educator, and innovator in the Canadian health-food industry
He is the co-founder of the Harmonic Arts Botanical Dispensary, the director of the Wild Rose College of Natural healing, and the creator of the Herbal Jedi Youtube Channel, which has 150,000 subscribers
Share Structure
Management & Insiders: $69,000
40,318,139 shares (53.6% of outstanding shares) 9 months no trading + CSE escrow
Seed Round ($0.10): $454,000
4,540,000 shares (6.0% of outstanding shares) 6 months no trading
Series A ($0.25): $840,762
3,363,048 shares (4.5% of outstanding shares) 4 months no trading
Shell: $200,000
3,350,000 shares (4.5% of outstanding shares) free trading
Go-Public Financing ($0.50): $11,800,000
23,600,000 shares (31.4% of outstanding shares) free trading
Total Basic Shares Outstanding: 75,171,187
96% of all outstanding shares have selling restrictions
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.
Bright Minds Biosciences inc. DRUG.CSE
Sector: Medical, Pharmaceutical/mental health
Focus: Psilocybin
Bright Minds Biosciences inc. is quickly emerging as a front runner in the psychedelic space with a specific focus on Psilocybin. With multiple patents to their name in Japan, Canada, U.S and Europe as well as a world class research team, the company continues to refine the Psilocybin compound to enable safe medicinal use. Bright Minds Biosciences’ primary focus is providing relief for a variety of ailments and conditions, both physically and mentally with promising results.
Sector: Medical, Pharmaceutical/Mental health
Focus: Psilocybin/2nd generation psychedelics
Bright Minds Biosciences inc. is quickly emerging as a front runner in the psychedelic space with a specific focus on Psilocybin. With multiple patents to their name in Japan, Canada, U.S and Europe as well as a world class research team, the company continues to refine the Psilocybin compound to enable safe medicinal use. Bright Minds Biosciences’ primary focus is providing relief for a variety of ailments and conditions, both physically and mentally with promising results. With approximately $28 Million in their treasury, the company is well funded for the foreseeable future.
Comparables
Overview
Recent Private placement of $26 Million at $7.57/share issued with great interest.
Significant and recurring insider buying has been taking place since the issuance of the $7.57 private placement (information available on SEDAR).
Bright Minds holds two patents on variants of the psilocybin molecule - a second generation of refined psychedelics, currently held in Japan, U.S, Canada and Europe.
Licensed/granted patents until 2036.
Business model allows continued refinement and patent protection.
Solidifying patent rights and revenue premiums going forward.
Research on additional patents currently in progress.
Unmodified, Psilocybin and all psychedelic drugs present a variety of side-effects posing specific stress on the cardiovascular system.
Without modification, psilocybin requires approximately 4-6 hours to be completely metabolized - a significant drawback to the medication/therapy.
At present, psilocybin must be used in clinics with physician supervision in a formal medical setting to be legally administered.
Bright minds Biosciences plans to have clinical trials by the end of 2021.
Initial trials will included studies on Depression and application in Epilepsy patients.
Benefits (of psilocybin itself) have been medically documented in patients with PTSD, anxiety, psychosis and growth in neurons.
Bright Minds Biosciences’ patents include the following modifications:
faster metabolization throughout the body.
reduction in respiratory/cardiac issues/symptoms etc.
These patents result in much safer and efficient use with fewer to no side-effects.
The psilocybin variant Bright Minds produces will be consumed orally.
Oral consumption is highly sought after in the psychedelic space.
Other large companies in the psilocybin space are looking to synthesize and patent psilocybin (the compound) itself.
This approach is shortsighted and “first past the post” in nature regarding patent potential.
Only one company can obtain the patent and the rest will be destitute; no other company has modified the molecule/compound like Bright Minds Biosciences.
Bright Minds Biosciences’ approach allows for continued refinement of the compound thus improving the products’ efficacy as well as continually extending the patents’ life.
$36 million total funds have been raised outside of government grant funding. SEDAR does not include government grants and funding of which Bright Minds Biosciences is continuing to leverage to further their research.
Approximately $28 million in treasury.
Many of the bio engineers on this world class team have significant connections in the medical field.
Allows the conduct of research in universities for free (allows PHD/Doctorate candidates to do work on their thesis’) resulting in research/ product advancement for pennies on the dollar.
Bright Minds Biosciences’ compounds will be patented at the cost of approximately $20,000 per patient per year.
as opposed to competitors’ generic offerings which will only be able to garner $500 per patient per year for a far inferior product.
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.
Cross River Ventures Corp. CRVC.CSE
Sector: Mining, Precious metals
Focus: Gold
Cross River Ventures Corp. is a district scale, data driven explorer in the precious metals space based in Canada. CRVC’s approach creates value though the implementation of leading edge technologies resulting in an efficient, focused project development model. With a world class geology team including Rob Carpenter (formerly at Kaminak Gold) and now 100% ownership of a greenstone belt, they are well positioned for a discovery with their drill programs scheduled for 2021.
Sector: Mining, Precious metals
Focus: Gold
Cross River Ventures Corp. is a district scale, data driven explorer in the precious metals space based in Canada. CRVC’s approach creates value though the implementation of leading edge technologies resulting in an efficient, focused project development model. With a world class geology team including Rob Carpenter (formerly at Kaminak) and now 100% ownership of a greenstone belt, they are well positioned for a discovery with their drill programs scheduled for 2021.
Overview
Flagship Project: McVicar Gold Project Ontario, Canada
CRVC has assembled a world class geology team that is efficiency and data driven.
Through multiple strateigic acquisitions the company was able to consolidate an expansive now 100% owned land position in the Lang Lake Greenstone Belt.
Located approximately 150km east of Red Lake, and 80km west of Pickle Lake, in North-Western Ontario, Canada.
Historical property samples taken by BHP Canada produced:
34 samples with an average grade of 28.8 g/t Au.
Additional historical grab samples with grades as high as 578 g/t Au and 533.5 g/t Au.
With acquisitions as recent as 2021, the land package has increased to 119.5 km2 in size.
The consolidated portfolio possesses some of the best terrain in the world regarding economic gold deposits.
CRVC was able to acquire these prospective properties at a discount as modern target-mapping techniques such as LiDAR or high-res geophysics were not previously used in their analysis.
Corporate Presentation and Other Projects
2021 Exploration Plans
Q1: Continue compiling existing historical data of all acquired properties. Create a cohesive map of the land package in preparation to define priority targets.
Q2: Utilize LIDAR imagery and airborne magnetic surveys to create a digital scan of the property further identifying drill targets.
Q2: Field work, staking targets, prospecting and surface/grab sampling.
Q3: Additional sampling a; over-burden sampling of high priority targets.
Q4: Drill Programs to begin at prospective targets reaffirmed though technological scans and surveys.
Share Structure
Issued and Outstanding: 27,479,457
Warrants: 8,197,052
Stock Options: 1,586,250
Fully diluted: 37, 262,759
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.
Azincourt Energy AAZ.V
Sector: Mining/ Renewable energy
Focus: Uranium, Lithium
Azincourt Energy currently has a 70% stake in the eastern portion of the Preston uranium project with partner Skyharbour Resources and Dixie Gold Inc. This project is located in the Athabaska Basin, Saskatchewan, Canada which possesses one of the highest concentrations of uranium in the world.
Sector: Mining/ Renewable energy
Focus: Uranium, Lithium
Azincourt Energy currently has a 70% stake in the eastern portion of the Preston uranium project with partner Skyharbour Resources. This project is located in the Athabaska Basin, Saskatchewan, Canada which possesses one of the highest concentrations of uranium in the world.
Flagship Project: East Preston (Athabaska basin) Saskatchewan, Canada
Key Points:
Partnered with Skyharbour Resources and Dixie Gold Inc. for the project with a current 70% stake.
The Athabasca basin historically has the highest, richest concentrations of uranium in the world. Up to 100 times the world average.
Exploration companies have been in the area for over forty years.
Expansive land package over 450 Km2 in size.
Over $6 Million invested in drilling and defining targets over the last 3 years.
Large multi-million dollar producers with proven resources such as Cameco, Orano, Nexgen Energy, Fission, Denison among others with extensive land packages are in close proximity to Azincourt’s East Preston project.
Multiple high interest targets have been defined through a combination of HLEM, VTEM(tm) and gravity geophysical surveys throughout the entirety of the property.
The combination of these detailed scans and surveys produced an extensive target-map of the property allowing the geology team to coordinate efficient drilling programs.
Permits are in hand for a 2000m to 2500m drill program scheduled for early 2021.
Drill program is fully funded.
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.
Insuraguest Technologies Inc. ISGI.V
Sector: Insurance/Hospitality (“Insurtech” (insurance + technology))
Focus: InsuraGuest Technologies focuses on using the power of technology to deliver insurance digitally across all sectors, empowering customers by offering on-demand insurance products, anytime and anywhere.
Sector: Insurance/Hospitality (“Insurtech” (insurance + technology))
Focus: InsuraGuest Technologies focuses on using the power of technology to deliver insurance digitally across all sectors, empowering customers by offering on-demand insurance products, anytime and anywhere.
Comparable
Lemonade , a company in the industry has recently been assessed a $2 Billion valuation.
Key Clients
Market Cap: $1.95 Billion
Managing Assets value: $93 Billion
Offered Insuraguest access to 9,300 Hotels for their product
#1 Supplier of vacation rentals to AirBNB
Gave Insuraguest access to their 60,000 unit vacation rental network
Producing nearly $2 Billion in yearly revenue
Served over 150,000 Clients
7,500 Associates
Over 100 integrated software partners
Real-time data and insights and notifications for property managers
Key points
Profit Margins
(HUB international) $4.95 per room per night stayed. 10% goes to hotel revenue; $1.75 to insurance costs resulting in a %60 profit margin
(GUESTY) $11.95 per unit per night stayed on vacation rentals. Results in an 80% profit margin.
Massive market valuation: 6.8B nights stayed in the world last year (2019). 36B year market at $4.95/night
Insiders hold approx. %60 of outstanding shares.
General liability insurance has increased year over year at an alarming rate; up 40% in the last four years
Ranked #1 easiest system to use
Patented software which allows seamless integration between client and customer
Claims are submitted digitally and resolved in a timely fashion
Insurance is activated when checked in and deactivated when checked out digitally in real-time.
Insuraguest’s platform is based on a mandatory insurance basis per night stay.
Insuraguest has created an industry first by combining Property and casualty/accident and health insurance together.
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.
Deep-South Resources Inc. DSM.V
Sector: Mining/Base Metals
Focus: Copper
Key Points:
Quality resource based on substantial drilling and exploration since the 1970s drilling to date including 66,000m of drilling, metallurgical tests, geophysical surveys, geo-chemical sampling, mapping, modelling, resource estimates and a feasibility study. 10,000M Drill program announced for early 2021.
Sector: Mining/Base Metals
Focus: Copper
Key Points:
Quality resource based on substantial drilling and exploration since the 1970s drilling to date including 66,000m of drilling, metallurgical tests, geophysical surveys, geo-chemical sampling, mapping, modelling, resource estimates and a feasibility study. 10,000m drill program announced for early 2021
Flagship Project:
Haib Copper Project Karas region, Namibia (Africa)
10,000M Drill program announced for early 2021 with drills currently en route to site.
Expansive 370 km2 property which is part of the largest known copper porphyry in Africa.
Historical exploration work valued at US$35 million
Indicated: 3.1B lbs of copper resource to date (2021/01/01)
Inferred: 2.2B lbs of copper resource to date (2021/01/01)
In proximity of all essential utilities: paved roads/highway, national power grid, water supply & well-serviced local towns.
Processing plant to be located 4 km from the mine site.
Deposit is defined by diamond core drilling covering a surface area of 2.6 km2
Well documented historical drilling dating back to 1970.
Future Feasibility Study program (2022) will include:
Up to 12,000m of infill drilling in the high-grade areas to define the average grade of the area, to estimate a measured resource; this allows for the potential of a much higher mineral resource/grade estimate.
Geology/mineralogy of the property contains simple ore that is highly compatible with bio-heap leaching.
Results indicate copper recoveries of up to 96% are possible.
Overall recoveries of 80% to 82% are very achievable.
Bio-heap leaching significantly reduces extraction costs associated with mining up to 3-4x.
Ranked 1st in policy perception amongst African countries (14th globally) in the 2019 Fraser Institute Mining Survey (friendly jurisdiction).
Key Shareholders:
TECK resources 21%
Management and directors 19%
Total 40%
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.
Power Nickel inc. PNPN.V
Sector: Mining/Precious Metals, Base Metals
Focus: Gold, Nickel, Copper
Key Points:
Power Nickel inc. has made two noteworthy acquisitions with the (up to 80% earn-in) Nisk-1 Joint Venture with Critical Elements Lithium Corp. and now 100% owned Golden Ivan property. Power Nickel possess a robust portfolio of land packages In Canada and Chile diversifying in both Base metals and Precious metals markets.
(Formerly Chilean Metals inc. CMX.V)
Sector: Mining/Precious Metals, Base Metals
Focus: Gold, Nickel, Copper
Key Points:
Power Nickel has made two noteworthy acquisitions in the up to 80% earn-in Nisk-1 Joint Venture with Critical Elements Lithium Corp. and now 100% owned Golden Ivan property. Power Nickel possess a robust portfolio of land packages In Canada and Chile diversifying in both Base metals and Precious metals markets.
Flagship Project:
Nisk-1 JV Project, James Bay Territory, Quebec
Recently entered into a Joint Venture agreement with Critical Elements Lithium Corp. with an option to earn up to 80% interest in the property.
Composed of two blocks totaling 90 claims covering an area of 45.9 km2.
Close proximity to Hydro-Québec power lines and a road that heads north to the Eastmain River and beyond to the La Grande River area.
Currently known for Nickel/Copper deposits.
An NI 43-101 resource estimate was delivered in 2009 for Nisk-1 by RSW Inc. containing an average measured, indicated, and inferred resource of:
3 Million Tons Nickel at 0.96%.
3 Million Tons Copper at 0.065%.
3 Million Tons Cobalt at 1.02%.
Remains largely unexplored posing the potential for a much larger resource to be defined.
Tierra De Oro, Chile
56 Km2 sized project
Located 20 km east of both the Pan American Highway and Chile’s main power grid
Well-maintained gravel road access.
Potential for Year-round exploration.
Contains bulk-tonnage Gold, Silver and Copper exploration targets.
Largely unexplored with successful gold results from artisinal mining initiatives.
Most Recent Drill program produced intersects of 716 g / t Ag and 0.453% Cu over 2 meters in Hole 3 at the Chanchero zone.
Power Nickel has acquired additional properties for future sale to fund their flagship projects in the future.
Key Shareholders:
Insiders and private investors 24%
Total 60%
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.
Levitee Labs inc. LVT.CSE
LVT News Releases
Hello Everyone! We are pleased to bring to your attention a recent IPO in the psychedelics, health and wellness space: Levitee Labs inc. (LVT.CSE)
We recently had the privilege of speaking with Levitee Labs CEO: Pouya Farmand and were instantly drawn to their “Roll Up” model. In a sector currently worth over $100 Billion and climbing, Levitee labs is continually looking for opportunities to increase their footprint in the psychedelics space.
Levitee Labs possesses intellectual property in Monke Neutraceuticals and Sporeo Supply. It is projected that these two divisions alone will generate approximately 23% of the company’s total revenue with 77% being produced through their most recent and future acquisitions going forward.
As of July 21st 2021, the company issued a news release confirming the acquisition of five addictions clinics and three specialized pharmacies in Alberta, Canada. All eight facilities specialize in addictions treatment as well as pain and mental health management. In addition, all clinics and pharmacies are “turn-key” in nature resulting in immediate positive cashflow for the company starting at $1 million per year. (please see due diligence below).
We were impressed at the rate with which Mr. Farmand and his team were able to expand and generate positive cashflow since their recent Initial Public Offering and listing on the CSE. As mentioned above, within a week of lisiting, Levitee labs issued a flurry of news releases outlining multiple acquisitions.
It is our understanding that the company plans on reaching an eventual acquisition target of over $500 million in assets. To compliment their expansion, Levitee Labs is committed to making strategic acquisitions which can further bolster the efficiency and sales of their existing portfolio. In this way, the company looks to position itself to be a “one-stop-shop” conglomerate by:
Providing necessities for small to large scale cultivation of psychedelics,
Creating psychedelic based health and wellness products; and,
Offering alternative treatment from Medical clinics and pharmacies in order to alleviate pain, manage addictions and mental health.
With this most recent expansion, Levitee labs is poised to become the first EBITDA-positive psychedelics company with a projected 2021 revenue of $15.4m from all assets/revenue streams.
We recently took a position at 52 cents and will continue to add as this story unfolds. The company’s nearest competitors (see below) have an average market capitalization of ~$378 million. It is our opinion that Levitee Labs is poised to grow 7-10x from its current market value in due course.
In closing, we noted a well laid out share structure. With approximately 96% of all outstanding shares possessing selling restrictions at the time of writing and ~53% insider ownership, we see a solid base going forward stabilizing the share price.
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
See our overview below for additional details.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
Levitee Labs inc. LVT.CSE
Sector: Healthcare, Psychedelics, Alternative Medicine, Mental Health and Nutraceuticals
Focus: Integrative Wellness, Synergistic Acquisitions and Vertical Expansion
Company Overview:
Levitee Labs (CSE: LVT) (“Levitee” or the “Company”) is an integrative wellness company that is transforming the digital landscape of mental health, addiction treatment, and pain management. The Company operates as an efficient capital allocator through a growing portfolio of revenue-generating wellness assets that have highly synergistic qualities for extensive psychedelic adoption and integration.
Comparable Companies:
Field Trip Health (TSX: FTRP) (Market Capitalization: ~$412.1M) – the company runs ketamine infusion clinics across Canada and the US, in addition to building clinics to administer psychedelic therapies
Numinus Wellness (TSXV: NUMI) (Market Capitalization: ~$198.9M) – the company has an acquisition model for acquiring clinics and administering psychedelic therapies
Cybin (NEO: CYBN) (Market Capitalization: ~$525.1M) – a biotechnology company that focuses on the development of psychedelic therapeutics to treat various psychiatric and neurological conditions
Levitee Labs (CSE: LVT) (Market Capitalization: $39.7M)
The Company has huge potential for re-rating and upside with
the psychedelics market being valued at over $100B as of 2021
Levitee Labs possesses an approximate Enterprise Value (EV) of $26M
The average EV in the health & wellness psychedelics space reaches north of $300M (~11.5x sales multiple)
Financials:
Levitee Labs raised $10.5 million in its last financing round, which was held in escrow until the Company’s listing on the CSE on July 21st, 2021
The Company is committed to building a portfolio of cash-flow generating assets as highlighted by Levitee’s expected acquisition pipeline of over $500M
Levitee Labs projects a 2021E revenue of $15.4M and EBITDA of $1.4M
The Company is expected to be the first EBITDA-positive psychedelics company
The Company has constructed a diversified portfolio with an expected 77% of incoming revenue being derived from acquisition targets and 23% from internally developed assets such as Monke Nutraceuticals and Sporeo Supply
Divisions:
Newly completed and certified production facility in Port Coquitlam, B.C.
Produces the first commercial-grade offering of sterilized grain and
substrates for small to large-scale mushroom cultivation
Anticipated revenue of $1.2M per month with $800,000 in positive cashflow
Based on a monthly purchase agreement with MyGreenPlanet
Mushroom-focused supplements containing clinically assessed levels of bioavailability for polysaccharides and beta-glucans
Organic mushroom fruitbodies extracted 8-10x
Utilizes a variety of certified organic, non-GMO, gluten-free, adaptogens and nootropics
The product has 41% profit margins
Levitee Clinics:
Levitee has recently acquired six mental health, pain and addictions focused clinics with over 35,000 patients
These clinics specialize in pain and addiction management
This acquisition will make Levitee the largest non-government addiction clinic services provider in Alberta
70% of patient visits conducted through the clinics’ proprietary telemedicine technology, which is the first (provincially) to prescribe narcotics over telehealth
Levitee Pharmacies:
Levitee has acquired three pharmacies specializing in management of pain and addictions
The combined revenue of the healthcare-focused acquisitions is approximately $7.5M over the last twelve months with over $1M in positive cashflow
Business Model:
Levitee has assembled a comprehensive team with a wide range of expertise in complementary fields in order to:
Develop key partnerships,
Raise capital,
Identify key acquisition targets,
Pursue clinical initiatives,
Expand profitability of newly acquired assets resulting in:
Multiple revenue streams with which to continue this “Roll Up” business model
Management & Board of Directors:
Pouya Farmand – Chief Executive Officer & Co-Founder
Mr. Farmand is an experienced financier and entrepreneur with over 10 years of transaction experience in capital markets and M&A
He has been involved in a leading advisory role for over 35 transactions ranging from $1M to $50M
Kelly Abbott – Chief Operations Officer & Co-Founder
Mr. Abbott has over 10 years of experience in entrepreneurship and software development
He has previous experience as a successful founder, investor, and CEO, having owned and operated several private and public companies
Ken Osborne, CFA – Head of M&A, Co-Founder
Mr. Osborne is a capital markets professional with diverse experience and is currently a General Partner at Darkhorse Partners having previously worked as a Corporate Development Manager within the Mergers & Acquisitions group at Telus (TSX: T) (NYSE: TU)
He has covered over 20 capital raises with an aggregate transaction volume of approximately $500M in M&A activity
Yarrow Willard – Director
Yarrow is a second-generation Clinical Herbalist, Master Herbalist, educator, and innovator in the Canadian health-food industry
He is the co-founder of the Harmonic Arts Botanical Dispensary, the director of the Wild Rose College of Natural healing, and the creator of the Herbal Jedi Youtube Channel, which has 150,000 subscribers
Share Structure
Management & Insiders: $69,000
40,318,139 shares (53.6% of outstanding shares) 9 months no trading + CSE escrow
Seed Round ($0.10): $454,000
4,540,000 shares (6.0% of outstanding shares) 6 months no trading
Series A ($0.25): $840,762
3,363,048 shares (4.5% of outstanding shares) 4 months no trading
Shell: $200,000
3,350,000 shares (4.5% of outstanding shares) free trading
Go-Public Financing ($0.50): $11,800,000
23,600,000 shares (31.4% of outstanding shares) free trading
Total Basic Shares Outstanding: 75,171,187
96% of all outstanding shares have selling restrictions
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.
Paradigm Picks Newsletter 2021/Jun/21
Hello everyone,
Welcome to part 2 of our updates. We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Updates
Emerita Resources EMO : The current crown-jewel of our portfolio with a gain of 905% at the time of writing, Emerita Resources is still a monster in the making. Research Capital Corp. recently assessed EMO with a $3.30 price target. Please click here for an in depth breakdown by “Doc Jones the Resource Investor.”
This play was originally brought to our attention over a year ago by Castle Rising Media inc. In collaboration with them, it became clear to us that the down-side would be in the $2.00 range with the potential upside in the $10.00+ range. Based on available historical resources we took our largest position in this company and are quite pleased we have! We believe this company is still in it’s infancy with confirmed resources in the ground out side of additional drilling/field work being completed. If/When Aznalcollar is awarded to EMO, the company will unquestionably see a significant increase in valuation.
Bright Minds Biosciences DRUG : As per the recent news release, $DRUG has made application to list on the NASDAQ. In our opinion this is a huge and welcomed step to increase accessibility, awareness, liquidity and validation of this company. In addition, the company has added:
- Emer Lahey, PhD, MBA, to join the Board of Directors; and,
- Tom Lategan, PhD, appointed to Vice President of Regulatory Affairs
to their team.
It has become clear to us that this company is taking the strategic steps to become a heavyweight - in not only the psychedelics space, but in the Pharmaceutical industry as a whole. We continue to watch this company with great interest.
Deep South Resources DSM : In relation to the latest press release regarding the HAIB copper licence renewal, we believe a strategic buying opportunity has presented itself.
Pierre Léveillé, President & CEO of Deep-South stated, "In the context that the Company is well funded and moving ahead with a large development program, the decision of the Minister is surprising and certainly not in the best interest of the development of the mineral resources of Namibia. We believe that a meeting with the Minister will remove any possible misunderstanding and the situation will be rectified in the shortest time frame possible. We are hopeful that our efforts to meet with the Minister will reach a positive outcome”
In its application for renewal and subsequent representations made to the Ministry, the Company has clearly demonstrated that it adequately meets the criteria under the Minerals (Prospecting and Mining) Act (Namibia) (the “Act”) to justify the renewal of its Licence. Accordingly, the Company is of the opinion that the refusal is unreasonable.
As a result, we have purchased a significant number of shares with an average of .122. In our opinion, this issue will soon be rectified resulting a share price reaching back into the .18-.22 range in short order.
Cross River Ventures CRVC : In speaking with CEO Alex Klenman, we were informed that as per our previous coverage of the company, CRVC is progressing well and on schedule. The company has been meeting its’ quarterly objectives and is engaged with the mapping/sampling process. We have also noticed as per SEDAR, Mr. Klenman as been adding to his position in recent weeks. We look forward to their future drill programs once the preliminary ground work has been completed.
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Paradigm Picks Newsletter 2021/Jun/07
Hello everyone,
We have been reaching out to the CEO’s of our various investments to stay up-to date on their respective progress and initiatives. As always, due to legal reasons, CEO’s may be “tight lipped” regarding various questions however provide a general sentiment for their projects going forward.
For real-time updates and commentary, follow us on Twitter at:
Paradigm Market Research Inc. (@PMResearch_ca) / Twitter
Updates
Chilean Metals inc. CMX : News to be released shortly. Currently finalizing the release with their lawyers.
Manning Ventures MANN : Continuing to be strategic in land acquisitions. Recently acquired an additional 144 Ha in iron ore projects. Preparing for surface sampling.
Azincourt Energy AAZ : Mineralization appears to be improving from previous drill holes. Assay results have been slow however are underway.
Insuraguest Technologies inc. ISGI : Additional contracts in the works. Interest/inquiries in the technology and brand continuing to increase.
Nexus Gold Corp. NXS : Drilling “going very well.” Working on defining the resource in the context of previous assays/samples. Both Dakouli and Red lake are showing promise and are actively being drilled. (Multiple pictures have been posted on social media depicting visible gold in multiple cores.)
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
If you have any further questions about these companies, please do not hesitate to contact us. We are more than happy to assist you with real-time, up-to-date information.
Bright Minds Biosciences DRUG.CSE
DRUG News Releases
Welcome back! We are pleased to bring to your attention to our latest investment in Bright Minds Biosciences (DRUG.CSE).
We recently had the privilege of speaking with Bright Minds’ CEO Ian Mcdonald and were incredibly impressed with the product, research, financial backing and world class research team assembled.
Bright Minds’ specializes in the development and patenting of 2nd generation psychedelics with a specific focus on modifying the Psilocybin compound into a medically approved, orally consumable therapeutic treatment. The company currently has two worldwide patents to their name which are valid until 2036 with ongoing research for additional patents. Clinical trials are expected to commence by the end of 2021. These initial trials will focus on Epilepsy and Depression.
What we find sets Bright Minds Biosciences apart from their competitors is the continual refinement of their proprietary compounds which ensures patent protection and premium revenue for years going forward. These patents focus on oral consumption, increase in metabolization throughout the body and significant reduction in side-effects; in particular those that affect the cardiovascular system.
We initially bought into the DRUG.CSE private placement at $7.57/share and have since doubled our position at $4.95/share. We believe that this company is poised to become a front-runner in the psychedelics space and are anticipating a significant return of 5-10x in due time.
In addition, CEO Ian Mcdonald has purchased a significant number of shares post private placement; in our opinion this certainly shows management’s conviction regarding the success of the company going forward.
With approximately $28 Million in their treasury at the time of writing, Bright Minds Biosciences is certainly well-heeled to continue their cutting-edge research for the foreseeable future.
As always, seek professional financial advice and conduct your own due diligence prior to making any investment decisions,
Paradigm Market Research inc.
See our overview below for additional details.
Consider supporting our free newsletter at: https://www.paradigmresearch.ca/our-team
Check out www.paradigmresearch.ca to view more of our content.
Bright Minds Biosciences inc. DRUG.CSE
Sector: Medical, Pharmaceutical/Mental health
Focus: Psilocybin/ 2nd generation psychedelics
Bright Minds Biosciences inc. is quickly emerging as a front runner in the psychedelic space with a specific focus on Psilocybin. With multiple patents to their name in Japan, Canada, U.S and Europe as well as a world class research team, the company continues to refine the Psilocybin compound to enable safe medicinal use. Bright Minds Biosciences’ primary focus is providing relief for a variety of ailments and conditions, both physically and mentally with promising results. With approximately $28 Million in their treasury, the company is well funded for the foreseeable future.
Comparables
Overview
Recent Private placement of $26 Million at $7.57/share issued with great interest.
Significant and recurring insider buying has been taking place since the issuance of the $7.57 private placement (information available on SEDAR).
Bright Minds holds two patents on variants of the psilocybin molecule - a second generation of refined psychedelics, currently held in Japan, U.S, Canada and Europe.
Licensed/granted patents until 2036.
Business model allows continued refinement and patent protection.
Solidifying patent rights and revenue premiums going forward.
Research on additional patents currently in progress.
Unmodified, Psilocybin and all psychedelic drugs present a variety of side-effects posing specific stress on the cardiovascular system.
Without modification, psilocybin requires approximately 4-6 hours to be completely metabolized - a significant drawback to the medication/therapy.
At present, psilocybin must be used in clinics with physician supervision in a formal medical setting to be legally administered.
Bright minds Biosciences plans to have clinical trials by the end of 2021.
Initial trials will included studies on Depression and application in Epilepsy patients.
Benefits (of psilocybin itself) have been medically documented in patients with PTSD, anxiety, psychosis and growth in neurons.
Bright Minds Biosciences’ patents include the following modifications:
faster metabolization throughout the body.
reduction in respiratory/cardiac issues/symptoms etc.
These patents result in much safer and efficient use with fewer to no side-effects.
The psilocybin variant Bright Minds produces will be consumed orally.
Oral consumption is highly sought after in the psychedelic space.
Other large companies in the psilocybin space are looking to synthesize and patent psilocybin (the compound) itself.
This approach is shortsighted and “first past the post” in nature regarding patent potential.
Only one company can obtain the patent and the rest will be destitute; no other company has modified the molecule/compound like Bright Minds Biosciences.
Bright Minds Biosciences’ approach allows for continued refinement of the compound thus improving the products’ efficacy as well as continually extending the patents’ life.
$36 million total funds have been raised outside of government grant funding. SEDAR does not include government grants and funding of which Bright Minds Biosciences is continuing to leverage to further their research.
Approximately $28 million in treasury.
Many of the bio engineers on this world class team have significant connections in the medical field.
Allows the conduct of research in universities for free (allows PHD/Doctorate candidates to do work on their thesis’) resulting in research/ product advancement for pennies on the dollar.
Bright Minds Biosciences’ compounds will be patented at the cost of approximately $20,000 per patient per year.
as opposed to competitors’ generic offerings which will only be able to garner $500 per patient per year for a far inferior product.
If you have any further questions about this company, please do not hesitate to contact us. We are more than happy to assist you with real-time, up to date information.